Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC
CLDX2 quarters
Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in Celldex Therapeutics, Inc.
VANGUARD PORTFOLIO MANAGEMENT LLC holds 863,536 shares of CLDX (Celldex Therapeutics, Inc.), worth $32.1M as of 2026-Q2. The position was increased (+37.2% shares). CLDX represents 0.0% of VANGUARD PORTFOLIO MANAGEMENT LLC's portfolio.
Current Value
$32.1M
Current Shares
863,536
Total Value Change
+$12.2M
Total Shares Change
+234,284
Quarter-by-Quarter History
Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP